Trial Profile
Pantoprazole in patients with NSAID-induced gastrointestinal damage
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2012
Price :
$35
*
At a glance
- Drugs Pantoprazole (Primary)
- Indications NSAID-induced gastrointestinal damage
- Focus Pharmacogenomic; Therapeutic Use
- 17 Jan 2012 New trial record
- 01 Dec 2011 Results published in Digestion.